{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:33:36Z","timestamp":1784543616412,"version":"3.55.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007258","name":"State University of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>On August 7\u20139, 2024, the second annual dengue \u201cendgame\u201d summit was held in Syracuse, NY, hosted by the Global Health Institute at SUNY Upstate Medical University. The meeting brought together attendees from around the world, with talks spanning healthcare, government control programs, basic research, and medical countermeasure development efforts. The summit goal was to work toward a better understanding of what dengue control could look like and the steps required to reach such a goal. The objectives of the meeting were to discuss the current global state of dengue, what dengue \u201ccontrol\u201d might look like, and to discuss actionable pathways for achieving dengue control. Topics covered throughout the meeting included DENV immunity and pathogenesis, challenges in countermeasure development, innovative vector control strategies, dengue diagnostics, addressing challenges in science communication, and vaccine hesitancy. Several fundamental knowledge gaps were repeatedly highlighted by the summit attendees and were cited as critical barriers to the development, deployment, and evaluation of effective dengue countermeasures. These gaps include (1) the lack of a broadly applicable immunologic biomarker\/correlate of DENV immunity and (2) the lack of universally accepted\/applicable metrics for quantifying dengue severity in the setting of countermeasure evaluations. In addition, the lack of clear and consistent international leadership in the global dengue control effort was cited as a barrier to widespread and synergistic research and countermeasure development\/deployment activities. Despite these persistent roadblocks, summit attendees expressed optimism that holistic and multi-tiered approaches\u2014incorporating optimal use of existing and nascent countermeasure technologies deployed in collaboration with local communities\u2014could be effective in progressing toward dengue control.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013028","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:28:47Z","timestamp":1745861327000},"page":"e0013028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proceedings of the second annual dengue endgame summit: A call to action"],"prefix":"10.1371","volume":"19","author":[{"given":"C\u00e9line S.C.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Barba-Spaeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto T.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bonsignori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila M.S.","family":"Castanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Hamins-Puertolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Christofferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian W.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert I.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Alex","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Dorigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telisa","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-6714","authenticated-orcid":true,"given":"Adam T.","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"23","key":"pntd.0013028.ref001","doi-asserted-by":"crossref","first-page":"126071","DOI":"10.1016\/j.vaccine.2024.06.038","article-title":"Proceedings of the dengue endgame summit: imagining a world with dengue control","volume":"42","author":"AD Wegman","year":"2024","journal-title":"Vaccine"},{"issue":"6365","key":"pntd.0013028.ref002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"LC Katzelnick","year":"2017","journal-title":"Science"},{"issue":"7707","key":"pntd.0013028.ref003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"H Salje","year":"2018","journal-title":"Nature"},{"key":"pntd.0013028.ref004","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"SB Halstead","year":"2003","journal-title":"Adv Virus Res"},{"issue":"6","key":"pntd.0013028.ref005","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: knowns and unknowns","volume":"2","author":"SB Halstead","year":"2014","journal-title":"Microbiol Spectr"},{"key":"pntd.0013028.ref006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fimmu.2020.00334","article-title":"Cross-reactive immunity among flaviviruses","volume":"11","author":"APS Rathore","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"pntd.0013028.ref007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0974-777X.56257","article-title":"Anamnestic immune response to dengue and decreased severity of yellow Fever","volume":"1","author":"RO Izurieta","year":"2009","journal-title":"J Glob Infect Dis"},{"issue":"6427","key":"pntd.0013028.ref008","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"I Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"issue":"10","key":"pntd.0013028.ref009","doi-asserted-by":"crossref","first-page":"e1311","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand","volume":"5","author":"KB Anderson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"6507","key":"pntd.0013028.ref010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"LC Katzelnick","year":"2020","journal-title":"Science"},{"issue":"749","key":"pntd.0013028.ref011","doi-asserted-by":"crossref","first-page":"eadn2199","DOI":"10.1126\/scitranslmed.adn2199","article-title":"Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1","volume":"16","author":"JV Zambrana","year":"2024","journal-title":"Sci Transl Med"},{"issue":"1","key":"pntd.0013028.ref012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.virol.2005.09.036","article-title":"Class II virus membrane fusion proteins","volume":"344","author":"M Kielian","year":"2006","journal-title":"Virology"},{"issue":"1","key":"pntd.0013028.ref013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-A resolution","volume":"20","author":"X Zhang","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"pntd.0013028.ref014","doi-asserted-by":"crossref","first-page":"e0070623","DOI":"10.1128\/mbio.00706-23","article-title":"New insight into flavivirus maturation from structure\/function studies of the yellow fever virus envelope protein complex","volume":"14","author":"E Crampon","year":"2023","journal-title":"mBio"},{"issue":"1","key":"pntd.0013028.ref015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-virology-092917-043300","article-title":"The many faces of a dynamic virion: implications of viral breathing on flavivirus biology and immunogenicity","volume":"5","author":"KA Dowd","year":"2018","journal-title":"Annu Rev Virol"},{"issue":"10","key":"pntd.0013028.ref016","doi-asserted-by":"crossref","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"R de Alwis","year":"2014","journal-title":"PLoS Pathog"},{"issue":"2","key":"pntd.0013028.ref017","doi-asserted-by":"crossref","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic efficacy of antibodies lacking Fc\u03b3 receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]","volume":"9","author":"KL Williams","year":"2013","journal-title":"PLoS Pathog"},{"issue":"2","key":"pntd.0013028.ref018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"W Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"pntd.0013028.ref019","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-024-45806-x","article-title":"Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection","volume":"15","author":"A Santos-Peral","year":"2024","journal-title":"Nat Commun"},{"issue":"24","key":"pntd.0013028.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"A Grifoni","year":"2017","journal-title":"J Virol"},{"issue":"20","key":"pntd.0013028.ref021","doi-asserted-by":"crossref","first-page":"e2115790119","DOI":"10.1073\/pnas.2115790119","article-title":"Assessing the role of multiple mechanisms increasing the age of dengue cases in Thailand","volume":"119","author":"AT Huang","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"pntd.0013028.ref022","doi-asserted-by":"crossref","first-page":"105134","DOI":"10.1016\/j.ebiom.2024.105134","article-title":"A scoping literature review of global dengue age-stratified seroprevalence data: estimating dengue force of infection in endemic countries","volume":"104","author":"A Vicco","year":"2024","journal-title":"EBioMedicine"},{"issue":"3","key":"pntd.0013028.ref023","doi-asserted-by":"crossref","first-page":"e3001160","DOI":"10.1371\/journal.pbio.3001160","article-title":"Periodic synchronisation of dengue epidemics in Thailand over the last 5 decades driven by temperature and immunity","volume":"20","author":"B Garc\u00eda-Carreras","year":"2022","journal-title":"PLoS Biol"},{"issue":"4","key":"pntd.0013028.ref024","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/cid\/ciae360","article-title":"Obesity is associated with increased pediatric dengue virus infection and disease: a 9-year cohort study in Managua, Nicaragua","volume":"79","author":"R Mercado-Hernandez","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0013028.ref025","doi-asserted-by":"crossref","first-page":"19839","DOI":"10.1038\/s41598-020-76836-2","article-title":"Similarities and differences between the \u201ccytokine storms\u201d in acute dengue and COVID-19","volume":"10","author":"S Dayarathna","year":"2020","journal-title":"Sci Rep"},{"key":"pntd.0013028.ref026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"SN Crooke","year":"2019","journal-title":"Immun Ageing"},{"issue":"22","key":"pntd.0013028.ref027","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"H Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"pntd.0013028.ref028","first-page":"385","article-title":"Serum complement level in dengue hemorrhagic fever","author":"K Nishioka","year":"1974","journal-title":"Allerg Immunol (Leipz)"},{"issue":"19","key":"pntd.0013028.ref029","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM197311082891902","article-title":"The potential pathogenic role of complement in dengue hemorrhagic shock syndrome","volume":"289","author":"VA Bokisch","year":"1973","journal-title":"N Engl J Med"},{"issue":"8","key":"pntd.0013028.ref030","doi-asserted-by":"crossref","first-page":"e6782","DOI":"10.1371\/journal.pone.0006782","article-title":"Alternative complement pathway deregulation is correlated with dengue severity","volume":"4","author":"EJ Nascimento","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"pntd.0013028.ref031","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00003-12","article-title":"Role of complement in dengue virus infection: protection or pathogenesis?","volume":"3","author":"S Shresta","year":"2012","journal-title":"mBio"},{"key":"pntd.0013028.ref032","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virusres.2013.11.007","article-title":"C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells","volume":"179","author":"B Douradinha","year":"2014","journal-title":"Virus Res"},{"issue":"1","key":"pntd.0013028.ref033","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1038\/s41598-020-65939-5","article-title":"Analysis of cell-associated DENV RNA by oligo(dT) primed 5\u2019 capture scRNAseq","volume":"10","author":"MA Sanborn","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"pntd.0013028.ref034","first-page":"718","article-title":"B cells are the principal circulating mononuclear cells infected by dengue virus","volume":"30","author":"AD King","year":"1999","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"12","key":"pntd.0013028.ref035","article-title":"Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status","volume":"7","author":"A rikiatkhachorn","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"pntd.0013028.ref036","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","article-title":"Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach","volume":"24","author":"L Ghita","year":"2023","journal-title":"Nat Immunol"},{"issue":"10","key":"pntd.0013028.ref037","doi-asserted-by":"crossref","first-page":"e1012683","DOI":"10.1371\/journal.ppat.1012683","article-title":"B cell receptor dependent enhancement of dengue virus infection","volume":"20","author":"C Gebo","year":"2024","journal-title":"PLoS Pathog"},{"issue":"4","key":"pntd.0013028.ref038","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","article-title":"In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody","volume":"140","author":"SB Halstead","year":"1979","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0013028.ref039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"SB Halstead","year":"1973","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0013028.ref040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"SB Halstead","year":"1973","journal-title":"J Infect Dis"},{"issue":"50","key":"pntd.0013028.ref041","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","article-title":"Mouse models of dengue virus infection for vaccine testing","volume":"33","author":"VV Sarathy","year":"2015","journal-title":"Vaccine"},{"issue":"20","key":"pntd.0013028.ref042","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"S Shresta","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"pntd.0013028.ref043","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"VV Sarathy","year":"2015","journal-title":"J Virol"},{"issue":"26","key":"pntd.0013028.ref044","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.vaccine.2010.04.045","article-title":"Report of an NIAID workshop on dengue animal models","volume":"28","author":"MC Cassetti","year":"2010","journal-title":"Vaccine"},{"key":"pntd.0013028.ref045","doi-asserted-by":"crossref","first-page":"621164","DOI":"10.3389\/fimmu.2021.621164","article-title":"Tree shrew as a new animal model for the study of dengue virus","volume":"12","author":"L Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"pntd.0013028.ref046","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.virol.2014.01.015","article-title":"Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis","author":"BM Althouse","year":"2014","journal-title":"Virology"},{"key":"pntd.0013028.ref047","article-title":"Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial","author":"KE Lyke","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0013028.ref048","doi-asserted-by":"crossref","first-page":"e1009240","DOI":"10.1371\/journal.ppat.1009240","article-title":"Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections","volume":"17","author":"AT Waickman","year":"2021","journal-title":"PLoS Pathog"},{"issue":"668","key":"pntd.0013028.ref049","doi-asserted-by":"crossref","first-page":"eabo5019","DOI":"10.1126\/scitranslmed.abo5019","article-title":"Evolution of inflammation and immunity in a dengue virus 1 human infection model","volume":"14","author":"AT Waickman","year":"2022","journal-title":"Sci Transl Med"},{"issue":"5","key":"pntd.0013028.ref050","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41564-024-01668-z","article-title":"Low-dose dengue virus 3 human challenge model: a phase 1 open-label study","volume":"9","author":"AT Waickman","year":"2024","journal-title":"Nat Microbiol"},{"issue":"2","key":"pntd.0013028.ref051","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiaa351","article-title":"A phase 1, open-label assessment of a dengue virus-1 live virus human challenge strain","volume":"223","author":"TP Endy","year":"2021","journal-title":"J Infect Dis"},{"issue":"330","key":"pntd.0013028.ref052","doi-asserted-by":"crossref","first-page":"330ra36","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"BD Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"key":"pntd.0013028.ref053","doi-asserted-by":"crossref","unstructured":"Pierce KK, Durbin AP, Walsh MR, Carmolli M, Sabundayo BP, Dickson DM, et al. TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies. J Clin Invest. 2024;134(3).","DOI":"10.1172\/JCI173328"},{"issue":"1","key":"pntd.0013028.ref054","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/s41467-021-22930-6","article-title":"Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model","volume":"12","author":"JP Hanley","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"pntd.0013028.ref055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2301790","article-title":"Live, attenuated, tetravalent Butantan-dengue vaccine in children and adults","volume":"390","author":"EG Kall\u00e1s","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"pntd.0013028.ref056","doi-asserted-by":"crossref","first-page":"2046960","DOI":"10.1080\/21645515.2022.2046960","article-title":"A phase I randomized double-blind placebo-controlled study to evaluate the safety tolerability and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naive and flavivirus-experienced healthy adults.","volume":"18","author":"KL Russell","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"38","key":"pntd.0013028.ref057","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1016\/j.vaccine.2023.07.045","article-title":"A phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults","volume":"41","author":"B Gunale","year":"2023","journal-title":"Vaccine"},{"key":"pntd.0013028.ref058","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-7-22","article-title":"Detection of dengue virus in saliva and urine by real time RT-PCR","volume":"7","author":"TR Poloni","year":"2010","journal-title":"Virol J"},{"issue":"36","key":"pntd.0013028.ref059","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1039\/C6CC00617E","article-title":"Towards vast libraries of scaffold-diverse, conformationally constrained oligomers","volume":"52","author":"T Kodadek","year":"2016","journal-title":"Chem Commun (Camb)"},{"issue":"21","key":"pntd.0013028.ref060","doi-asserted-by":"crossref","first-page":"e2312755121","DOI":"10.1073\/pnas.2312755121","article-title":"Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope","volume":"121","author":"PMS Castanha","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"pntd.0013028.ref061","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/jiac177","article-title":"Individual, household, and community drivers of dengue virus infection risk in Kamphaeng Phet Province, Thailand","volume":"226","author":"G Ribeiro Dos Santos","year":"2022","journal-title":"J Infect Dis"},{"issue":"7","key":"pntd.0013028.ref062","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/aje\/kwaa008","article-title":"An innovative, prospective, hybrid cohort-cluster study design to characterize dengue virus transmission in multigenerational households in Kamphaeng Phet, Thailand","volume":"189","author":"KB Anderson","year":"2020","journal-title":"Am J Epidemiol"},{"issue":"11","key":"pntd.0013028.ref063","doi-asserted-by":"crossref","first-page":"e2213701120","DOI":"10.1073\/pnas.2213701120","article-title":"RNA interference is essential to modulating the pathogenesis of mosquito-borne viruses in the yellow fever mosquito Aedes aegypti","volume":"120","author":"GH Samuel","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"pntd.0013028.ref064","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1038\/s41467-023-41370-y","article-title":"Aedes aegypti Argonaute 2 controls arbovirus infection and host mortality","volume":"14","author":"S Dong","year":"2023","journal-title":"Nat Commun"},{"key":"pntd.0013028.ref065","doi-asserted-by":"crossref","first-page":"1368066","DOI":"10.3389\/fimmu.2024.1368066","article-title":"Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes","volume":"15","author":"S Chea","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"pntd.0013028.ref066","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JVI.03220-14","article-title":"Intricate roles of mammalian sirtuins in defense against viral pathogens","volume":"90","author":"HG Budayeva","year":"2016","journal-title":"J Virol"},{"issue":"12","key":"pntd.0013028.ref067","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158978","article-title":"An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity","volume":"133","author":"KL Roche","year":"2023","journal-title":"J Clin Invest"},{"issue":"8","key":"pntd.0013028.ref068","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1074\/jbc.M113.487736","article-title":"A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer","volume":"289","author":"G Hoffmann","year":"2014","journal-title":"J Biol Chem"},{"issue":"6366","key":"pntd.0013028.ref069","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"DBT Cox","year":"2017","journal-title":"Science"},{"issue":"6","key":"pntd.0013028.ref070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents","volume":"39","author":"EL Blanchard","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"8","key":"pntd.0013028.ref071","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41564-024-01726-6","article-title":"mRNA-encoded Cas13 can be used to treat dengue infections in mice","volume":"9","author":"M Basu","year":"2024","journal-title":"Nat Microbiol"},{"issue":"2","key":"pntd.0013028.ref072","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4.5-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"V Tricou","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"7","key":"pntd.0013028.ref073","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.vaccine.2023.01.007","article-title":"A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country","volume":"41","author":"V Tricou","year":"2023","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0013028.ref074","doi-asserted-by":"crossref","first-page":"e0011124","DOI":"10.1371\/journal.pntd.0011124","article-title":"Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: a phase 3 randomized, controlled study","volume":"17","author":"V Tricou","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0013028.ref075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope","volume":"162","author":"LN Robinson","year":"2015","journal-title":"Cell"},{"issue":"7953","key":"pntd.0013028.ref076","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"O Goethals","year":"2023","journal-title":"Nature"},{"issue":"5","key":"pntd.0013028.ref077","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a first-in-class pan-serotype dengue virus NS4B inhibitor","volume":"67","author":"B Kesteleyn","year":"2024","journal-title":"J Med Chem"},{"key":"pntd.0013028.ref078","first-page":"2024.08.10.24311393","article-title":"Efficacy, public health impact and optimal use of the Takeda dengue vaccine","author":"BC Daniels","year":"2024","journal-title":"medRxiv"},{"key":"pntd.0013028.ref079","year":"2025"},{"key":"pntd.0013028.ref080","author":"Prevention, C.f.D.C.a","year":"October 2, 2024"},{"issue":"10370","key":"pntd.0013028.ref081","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(22)01693-2","article-title":"The legacy of the COVID-19 pandemic for childhood vaccination in the USA","volume":"401","author":"DJ Opel","year":"2023","journal-title":"Lancet"},{"key":"pntd.0013028.ref082","article-title":"Give a Strong Vaccine Recommendation.","author":"Prevention C.f.D.C.a","year":"2025"},{"key":"pntd.0013028.ref083","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-94694-8","volume-title":"The Clinician\u2019s Vaccine Safety Resource Guide Optimizing Prevention of Vaccine-Preventable Diseases Across the Lifespan","author":"MZS Dudley","year":"2018"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T17:28:59Z","timestamp":1745861339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013028"}},"subtitle":[],"editor":[{"given":"Alexander","family":"Bukreyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":83,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013028","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}